CENTRO DI DOCUMENTAZIONE SUI DISPOSITIVI MEDICI

 REGOLAMENTO DISPOSITIVI MEDICI: RISCHIO RITARDI? MEDICAL DEVICES REGULATION: RISK OF DELAYS? Luca Martinelli Pubblicazione 24 dicembre 2020  ITA   1.PREMESSA A fine agosto di quest’anno la commissione Europea, attraverso l’EU Survey, ha invitato tutti e 54 gli organismi notificati a partecipare a un’indagine denominata “MDR: Aumentare la trasparenza del processo di designazione MDR 08-2020”.   Obiettivo dell’indagine era quello di verificare la trasparenza e le capacità degli organismi notificati al fine di consentire un’efficace attuazione del regolamento dispositivi medici che ricordiamo sarà di applicazione obbligatoria dal maggio dell’anno prossimo. Un altro scopo del sondaggio era anche quello di avere informazioni aggiornate sul processo di designazione che come sappiamo vede per adesso appena 17 organismi che hanno ottenuto la notifica di cui italiani solo 1 ovvero l’IMQ. Il sondaggio serviva per avere un’idea dei certificati soggetti a transizione da diret...

MDD REGULATION TRANSITION TIME - STOP THE CLOCK (?) MedTech Europe   -  Original publisher MedTech Europe is calling on the European Commission, European Parliament and all EU Member States, to have an urgent discussion of solutions that will ensure that there is appropriate time for the systems to be ready to function. The industry calls for: • Actions to address challenges on the transition timing Industry envisages at least three options to be explored either alone or in combination: a) A ‘stop the clock’ mechanism, that freezes the remaining transition time for both regulations until full readiness of the system has been achieved; b) An extension of the critical dates of 26 May 2020 and 26 May 2022, for all products; c) An extension of the critical dates of 26 May 2020 and 26 May 2022, for legacy products only. Options b) and c) would require a specific timeline to be agreed upon. • Actions to make the ‘grace period’ an effective instrument and...

From WebSite The recent  scandals  related to metal-on-metal artificial hips or  faulty silicone breast implants  have strengthened the case for modernising current rules for medical devices. On 7 March 2017, the Council adopted new EU rules improving the safety of medical devices for the benefit of patients while preserving a timely access to innovative healthcare solutions. The two new EU regulations (MDD & IVDMDD): -provide a stronger mandate to independent notified bodies in their assessment of medical devices before they can be placed on the market, and strengthen the oversight of these bodies by national authorities; the new rules also ensure that notified bodies meet the same high safety standards throughout the EU; these measures will  improve the safety of medical devices; -improve the availability of clinical data on devices and clearly set out manufacturers' responsibilities for the follow-up of the quality, performance an...